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the macroscale effects that occur with varying 
concentrations of GNPs.  
 
Material and Methods: Within our model, concentrations of 
NPs were simulated by calculating the inter-particle spacing 
of various concentrations, where this spacing was used to 
model a controllable concentration, whilst minimizing 
computational time. Investigations were carried out on the 
effect of concentration over a range of clinically relevant 
concentrations in line with previous studies (0.01 mg/ml, 0.1 
mg/ml and 6.5 mg/ml) [1], [2], [3] at two incident proton 
energies (60 MeV and 226 MeV). Various results were 
recorded, such as the energy deposited across the phantom, 
types of secondary particles produced, the particle track 
lengths and energy deposited by secondary particles. 
 
Results: The results highlight a measurable shift of the distal 
edge (Fig.1) in the order of millimeters due to the 
introduction of gold, which can be seen predominantly at 
high concentrations (6.5 mg/ml) achievable through direct 
injection. This shift was deemed to be energy dependent, 
where at lower energies (60 MeV) it was on the order of 
microns. As demonstrated by other groups, the enhancement 
was attributed to an increase in the number of secondary 
electrons, which was proportional to GNP concentration as 
expected. Our model demonstrates that the magnitude of the 
effects observed can be related to the concentration. 
 
 
 
Figure 1: A zoomed in section of the peak, where the plot 
shows readings at every millimeter using a 226 MeV proton 
beam, highlighting the differences due to gold 
concentrations. 
 
Conclusion: This study has demonstrated bulk effects of 
multiple NPs on dosimetry, extending previous work on single 
NP models by other groups [4]. Results show that injectable 
concentrations can affect the range of protons, proving to be 
more significant at higher energies. Future work will 
investigate the effects that GNPs can have on treatment 
plans, assessing any changes that need to be made.  
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Purpose or Objective: A methodology has been developed 
for comprehensive clinical quality audits of radiation therapy 
programmes called Quality Assurance Team for Radiation 
Oncology (QUATRO). The purpose of these audits, which are 
distinct from accreditation, is to assist the audited centres in 
identifying and implementing opportunities for improving the 
quality of services offered to patients. Aggregating the 
findings from audits carried out over 10 years in Europe sheds 
light on the degree to which various dimensions of quality are 
satisfied and suggests interventions which are likely to be 
effective in improving quality in the audited centres. 
 
Material and Methods: Thirty one centres in Europe have 
been audited with this methodology since 2005. The 
voluntary, confidential audits are conducted by 
multidisciplinary teams and take 5 days on-site to complete. 
Reports to the audited centres include both commendations, 
i.e. positive findings, and recommendations for quality 
improvement. A subset of the audited centres were 
designated Centres of Competence (CCs) through QUATRO. A 
coding key has been developed to aggregate and analyse the 
extensive data generated from this audit series. 
 
Results: 600 commendations and 759 recommendations for 
improvement were noted in the 31 audit reports. Positive 
attributes of the audited centres included patient 
centredness, communication, facilities (with the marked 
exception of the availability of treatment units) and quality 
control. Areas for improvement included staffing and 
equipment levels, professional development, documentation 
and quality management. Overall, 10 centres were 
designated as CCs. Of the 600 commendations, 220 were 
given to 10 CCs and 380 to other centres. Of the 759 
recommendations, CCs received 82 while the other centres 
677. The levels of physicists and RTT staffing generally met 
international recommendations in CCs whereas in the other 
centres major staff shortages were recorded. RTT 
understaffing was most acute but other staff groups also 
needed strengthening. Education, training and professional 
development of all staff, but especially RTTs, was seen as a 
weakness in many centres. 
 
Conclusion: QUATRO audits provided the radiotherapy 
centres with an opportunity for an in depth analysis of their 
practices. The detailed reports constitute a template for 
practice improvement and highlight the need to develop 
strategies on the future development of radiotherapy 
services. The analysis of the 31 audits has also identified the 
need for common action items for enhancing the quality of 
radiotherapy in the audited centres. In particular, there is a 
need for extending the reach of educational programmes and 
for expanding the educational offerings to include quality 
management and associated topics. 
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Purpose or Objective: NHS England selected 17 centres of 
varying experience to take part in the Commissioning through 
Evaluation (CtE) programme in order to improve access to 
SABR for patients with Oligometastatic disease. A QA group 
was formed from members of a national trials QA group and a 
national SABR development group to ensure patient safety 
and treatment quality across participating centres, which 
utilise a variety of different equipment and techniques. 
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Material and Methods: A bespoke QA programme was 
created for the 5 anatomical treatment sites which included 
spine and nodal metastasis. Prior to treatment centres were 
required to complete a QA process which included planning 
benchmark cases. Participating centres were provided with a 
pre-outlined planning CT. They created PTV expansions using 
local protocols. The centres were then required to create a 
plan based on a 30 Gy in 3 fraction prescription for the nodal 
case and a 24 Gy in 3 fractions prescription for the spine 
case. Both cases required a D95% of the prescription dose for 
the PTV coverage whilst ensuring OAR tolerances were met. 
All planning benchmarks were submitted and centrally 
analysed using VODCA 5.4 plan review software. The 
coverage of the PTV and CTV with the prescription dose, 
doses to OARs and measures of conformity were calculated. 
The values for the different submissions were compared to 
ensure plans were of suitable quality and comparable across 
different treatment platforms.  
 
Results: A total of 10 and 11 plans were submitted for the 
spine and nodal benchmark cases respectively, including all 4 
NHS cyberknife centres and the remainder using VMAT. 27% 
of the nodal and 18% of the spine plans had unacceptable 
deviations and the centres were given feedback and asked to 
resubmit their QA. The PTV coverage and max dose were 
compared for the different treatment techniques with the 
standard deviation. These can be seen in the table below. 
 
 
 
A 2 tail Mann-Whitney test was performed on the PTV 
coverage data for both plans. This indicated that there was a 
significant difference between cyberknife and VMAT plans 
(p=0.02).  
 
Conclusion: Cyberknife plans on average achieved superior 
PTV coverage when compared to VMAT plans. This was more 
evident for the spine PTV and nodal PTV 1, with both volumes 
being close to OARs, than for the nodal PTV 2 where OARs did 
not restrict the dose . The VMAT plans involved larger PTV 
and PRV expansions which would partly explain the difficulty 
in achieving the required PTV coverage. However, several of 
the VMAT plans had similar PTV coverage to the cyberknife 
plans, hence the greater variation in PTV coverage of the 
VMAT plans may reflect possible inexperience in SABR 
planning for some centres. Following resubmissions, all 
centres participating in the CtE programme have been able to 
produce acceptable benchmark plans regardless of treatment 
platform.  
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Purpose or Objective: Preclinical studies are critical steps in 
the medical research process, normally requiring dedicated 
instruments. For those centers in which both preclinical 
research and clinical practices are conducted, the dosimetric 
feasibility of small animal irradiation with clinical devices 
may be of economical and scientific interest. The aim of the 
present work is to investigate the feasibility of small animal 
irradiation with Tomotherapy Hi-Art by analyzing dosimetric 
results, toxicity and tumour response in xenograft models. 
 
Material and Methods: Xenograft models were established by 
injecting human derived glioblastoma multiforme stem-like 
cells in immunocompromised NOD-SCID mice both 
subcutaneously (10 groups) and intracranially (7 groups). Mice 
of each group were anesthetized and placed in a plexiglas 
cage pie to perform CT scans for treatment planning 
purposes. Target volumes and organs at risk (OARs) where 
outlined on CT scans: for subcutaneous xenografts, target 
volumes were delineated on the right flank and contoured 
OARs were lung and gastro-intestinal tract. For orthotopic 
models, a ring-shaped target structure was delineated on 
mice’s head; contoured OAR was lung. Three fractionation 
schedules were tested: 4Gy/1 fraction, 4 Gy/2 fractions and 
6 Gy/3 fractions. TomoDirect IMRT technique was applied, 
with gantry fixed at 0° and 180. 5 subcutaneous and 1 
orthotopic groups of xenografts were irradiated by covering 
the target volume with a 0.6 cm bolus layer in order to 
reduce the impact of the build-up effect. Irradiations 
originally performed without bolus were simulated with a 0.6 
cm virtual bolus in order to compare dosimetric results. 
Before irradiation, a MVCT image has been acquired to 
correct irradiation setup. Mice were observed daily and 
sacrificed when they showed signs of suffering or when 
tumour volume reached the established endpoint. Different 
radiobiological outcomes were evaluated, regarding both 
radiotoxicity (survival experiments) and tumour response 
(assessed by caliper or bioluminescence imaging), comparing 
irradiated mice as respect to their controls. 
 
Results: Dosimetric results showed that the presence of the 
bolus layer significantly impact the maximum dose received 
by both target volumes and OARs (t-test, p<0.05). Survival 
analysis showed that irradiation with a dose of 6 Gy in 3 
fractions in the presence of a bolus layer prolong mice 
survival (Log-rank test, p<0.02), showing to be the safest 
irradiation protocol. Tumour volume response and mice 
survival were significantly different in irradiated xenografts 
as compared to their controls (t-test, p<0.03; Log-rank, 
p<0.05) demonstrating also the radiobiological potential of 
Tomotherapy in inducing tumour growth stabilization. 
 
Conclusion: Tomotherapy systems may be a useful mean for 
small animal irradiation.  
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Purpose or Objective: To evaluate the dosimetric properties 
of acrylonitrile butadiene styrene (ABS) and polylactide (PLA) 
plastics, and their suitability for bolus printing applied in 
high-energy radiotherapy to overcome the skin-sparing 
effect. 
 
Material and Methods: The measurements were performed 
with Vero® System (Brainlab AG, Feldkirchen, Germany) 
delivering 200 monitor units (dose rate of 500 MU/min) with a 
6 MV photon beam, 5x5 cm open field with 90-degree gantry 
angle at 100 cm surface to surface distance (SSD) on a water-
equivalent RW3 slab phantom in three configurations: 
without bolus, with a commercial bolus and with the eight 3D 
